Dr. Susan B. Bressler, The Julia G. Levy, PhD, Professor of Ophthalmology, Division of Ophthalmology at Johns Hopkins University School of Medicine in Baltimore, Maryland will review evidence which will enable participants to recognize the limitations of current knowledge regarding the impact of vitrectomy for DME.

What's New in Diabetic Retinopathy & Retinal Vein Occlusion

What Have We Learned about Vitrectomy for DME?

The treatment of diabetic retinopathy (DR) and retinal vein occlusion (RVO) is an increasingly complex and rapidly changing discipline with new information and techniques emerging. In addition, the incidence of DR and RVO is increasing dramatically. It is vital you remain up to date with the latest information, to insure your patients receive the optimal care. With that in mind, What's New in Diabetic Retinopathy & Retinal Vein Occlusion will review cutting edge therapies and techniques in DR and RVO.

About

What's New in Diabetic Retinopathy & Retinal Vein Occlusion